Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A
- DOI
- 10.1016/j.jval.2018.04.1670
- Published
- 2018-05
- Container
- Value in Health
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jval.2018.04.1670,
title = {Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A},
author = {R Ayyagari and C Deschaseaux and PB Vashi and S Kessabi and W Gao},
year = {2018},
journal = {Value in Health},
doi = {10.1016/j.jval.2018.04.1670},
url = {https://doi.org/10.1016/j.jval.2018.04.1670}
}RIS
TY - JOUR TI - Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A AU - R Ayyagari AU - C Deschaseaux AU - PB Vashi AU - S Kessabi AU - W Gao PY - 2018 JO - Value in Health DO - 10.1016/j.jval.2018.04.1670 UR - https://doi.org/10.1016/j.jval.2018.04.1670 ER -
APA
Ayyagari, R., Deschaseaux, C., Vashi, P., Kessabi, S., & Gao, W. (2018). Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A. Value in Health. https://doi.org/10.1016/j.jval.2018.04.1670
Source records
- crossref · retrieved 2026-09-25T20:39:41.469Z